The Treatment of Depression With Botulinum Type A Toxin (Botox): A Randomized, Double Blind, Crossover Study
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Jul 2011 New trial record